| |
|
|
|
Xtalks, online
2022 -11-08
The Clinical Data Interchange Standards Consortium (CDISC) compliance is now mandatory for clinical trial submissions to the US Food and Drug Administration (FDA) and Pharmaceuticals and Medical Devices Agency (PMDA). And for many academic institutions, this is now a condition of their grant funding. However, adopting CDISC standards isn’t just a necessity. It’s an important investment that enables more meaningful research, and easier data analysis, with deeper insights.
In addition, those who take steps to implement standards benefit from reuse. Rather than designing new studies from scratch, content can be reused across future studies and standards, enabling significant time and resource efficiencies.
Attendees will hear how the University of Alabama (UAB) and the University of Utah are tackling CDISC compliance and embracing the benefits of standardization. Experts from both universities will tell the story of their compliance journey — their starting point; what they were looking to achieve; what they needed help with; the challenges they faced; what they achieved; and future aspirations.
Attendees will have the opportunity to ask questions specifically related to their own organizational projects or specific challenges, and how best to address them.
Register to learn about the need for standardization and hear from CDISC themselves, including their guidance and approach to standards adoption.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Rhonda Facile, Vice President, Partnerships and Development, CDISC Coretta (Thomas) Robinson, Program Manager, The University of Alabama (UAB) Russ Telford, Director of Biostatistics and Clinical Data Management, The University of Utah Ed Chappell, Solutions Consultant, Formedix Mark Wheeldon, CEO, Formedix
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2022 -11-08
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|